{"url_path":"/sec/bntc/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1808898/0001193125-26-222879-index.html","accession_number":"0001193125-26-222879","cik":"0001808898","ticker":"BNTC","issuer_name":"Benitec Biopharma Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1808898/0001193125-26-222879-index.html","primary_entity_key":"0001808898","primary_entity_name":"Benitec Biopharma Inc."},"word_count":85,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n## (d) Exhibits\n\nExhibit No.\n\nDescription\n\n99.1\n\n[Press Release of Benitec Biopharma Inc. dated May 14, 2026](bntc-ex99_1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nBENITEC BIOPHARMA INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nMay 14, 2026\n\nBy:\n\n/s/ Dr. Jerel A. Banks\n\n \n\n \n\n \n\nDr. Jerel A. Banks\nChief Executive Officer"}